Company Filing History:
7 out of 815 
2 out of 110 
1 out of 1,178 
Years Active: 2018-2025
Title: Makoto Ikeya: Innovator in Cell Culture and Therapeutic Agents
Introduction
Makoto Ikeya is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the fields of cell culture and therapeutic agents, holding a total of 7 patents. His work focuses on innovative methods that enhance the proliferation and differentiation of neural crest cells, as well as developing therapeutic agents for specific medical conditions.
Latest Patents
One of Ikeya's latest patents is a method for the culture of cells. This technique allows for the proliferation of neural crest cells without compromising their differentiation capacity. The method involves obtaining neural crest cells and suspension-culturing them in a medium that includes a GSK3β inhibitor and basic fibroblast growth factor (bFGF). The concentration of the GSK3β inhibitor used is critical, as it must be higher than 1 μM and lower than 5 μM to achieve the desired effect.
Another significant patent is for a therapeutic agent aimed at fibrodysplasia ossificans progressiva. This invention includes at least one compound selected from a group that consists of rapamycin, temsirolimus, everolimus, ridaforolimus, TAFA93, umirolimus, olcorolimus, zotarolimus, and their pharmaceutically acceptable salts. This innovative approach offers new hope for patients suffering from this rare condition.
Career Highlights
Throughout his career, Makoto Ikeya has worked with esteemed institutions such as Kyoto University and Sumitomo Dainippon Pharma Co., Ltd. His research and inventions have garnered attention in the scientific community, contributing to advancements in medical therapies and cell culture techniques.
Collaborations
Ikeya has collaborated with notable colleagues, including Junya Toguchida and Kyosuke Hino. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.
Conclusion
Makoto Ikeya's innovative contributions to cell culture and therapeutic agents highlight his role as a leading inventor in his field. His patents not only advance scientific knowledge but also offer potential solutions for medical challenges.